Clinical trial: Remicade's effects on RA
(National Institutes of Health) UPDATED 2009-09-21
This is a study to assess the effectiveness of Remicade in rheumatoid arthritis (RA) patients who have not responded adequately to treatment with combinations of Humira and methotrexate or Enbrel and methotrexate. This international study is currently recruiting RA patients ages 18 years and older who meet these and other study criteria.
Read full story >
See all Rheumatoid Arthritis News